Showing results (51-60 of 198) with videos related to
Sort By:
Pageof 20
International Journal of Cancer|May 11, 2013
Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target?Nina Wolmer-Solberg, Ninib Baryawno, Afsar Rahbar, et al.Pharmacological Research|February 22, 2018
Molecular mechanisms and therapeutic targets in neuroblastomaJohn Inge Johnsen, Cecilia Dyberg, Susanne Fransson, et al.Frontiers in Oncology|February 15, 2021
MYCN Function in Neuroblastoma DevelopmentJörg Otte, Cecilia Dyberg, Adena Pepich, et al.Plos One|April 25, 2014
Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesisRaul Calero, Esther Morchon, John Inge Johnsen, et al.The Journal of Clinical Investigation|September 28, 2011
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic targetNinib Baryawno, Afsar Rahbar, Nina Wolmer-Solberg, et al.International Journal of Oncology|September 30, 2010
Suppression of RIZ in biologically unfavourable neuroblastomasJanos Geli, Nimrod Kiss, Per Kogner, et al.Cancers|May 25, 2024
The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic ApproachesPanagiotis Alkinoos Polychronopoulos, Oscar C Bedoya-Reina, John Inge JohnsenMolecular Cancer|June 15, 2012
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastomaAnna Djos, Tommy Martinsson, Per Kogner, et al.Cancer Cell International|March 17, 2021
The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastomaSimon Keane, Tommy Martinsson, Per Kogner, et al.Journal of Molecular Signaling|April 20, 2013
Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomasSusanne Fransson, Per Kogner, Tommy Martinsson, et al.Pageof 20